*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open it from there.
Public submissions made in response to:
- the delegates' proposed amendments to the Poisons Standard published on 21 December 2017 and received before the first closing date under regulation 42ZCZK of the Therapeutic Goods Regulations 1990 (the Regulations); and
- the delegates' interim decisions and invitation to comment published on 7 June 2018 and received before the second closing date under regulation 42ZCKP of the Regulations.
Public submissions on proposed amendments
- Public submissions on scheduling proposals referred to the March 2018 meeting of the ACMS #23 (pdf,1.1Mb)
- Public submissions on scheduling proposals referred to the March 2018 meeting of the Joint ACMS-ACCS #18 (pdf,400kb)
- Consent was not given to publish the public submissions on scheduling proposals referred to the March 2018 meeting of the ACCS #22
Public submissions on interim decisions
Proposed amendments referred to the ACMS #23
Diclofenac
No public submissions were received.
Cannabidiol, Cannabis and Tetrahydrocannabinols
No public submissions were received.
Fluticasone
No public submissions were received.
Proposed amendments referred to the Joint ACMS-ACCS #18
Prostaglandins
No public submissions were received.
Vinyl acetate
Proposed amendments referred to the ACCS #22
Mefentrifluconazole
No public submissions were received.
Moxidectin
No public submissions were received.
Eprinomectin
- Industry stakeholder - The submitter did not give permission to publish their name or submission
Supporting documents
Outcome of